Last updated: March 21, 2025
Sponsor: Mahmoud Rafaat Mohamed
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
Group 1: ultrasound guided wrist block with bupivacane alone
Group 3: ultrasound guided wrist block with bupivacane and dexametmiodine
Group 2 : ultrasound guided wrist block with bupivacane and dexamethasone
Clinical Study ID
NCT06826690
963-9-24
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients more than or equal 18 years old and are ASA 1-3
Exclusion
Exclusion Criteria:
allergy to used medication
pre exist neuropathy
coagulapthy
cognitive impairment
refusal to participate
Failed block and requiring general anesthesia
Study Design
Total Participants: 160
Treatment Group(s): 4
Primary Treatment: Group 1: ultrasound guided wrist block with bupivacane alone
Phase: 4
Study Start date:
February 02, 2025
Estimated Completion Date:
September 10, 2025
Study Description
Connect with a study center
Aswan university hospital
Aswan,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.